Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Inventory (2011 - 2023)

Perspective Therapeutics' (CATX) quarterly Inventory came in at $1.0 million in Q3 2023, down 34.77% year-over-year from $1.6 million in Q3 2022, and down 7.4% quarter-over-quarter from $1.1 million in Q2 2023.

Analysis

Perspective Therapeutics (CATX) Inventory (2011 - 2023) Analysis & Trends

Perspective Therapeutics has disclosed Inventory across 13 years of filings, most recently posting $1.0 million for Q3 2023.

  • In Q3 2023, Inventory fell 34.77% year-over-year to $1.0 million; the TTM figure through Sep 2023 stood at $1.0 million (down 34.77% YoY), while the FY2022 annual figure was $1.4 million, changed N/A from the prior year.
  • Inventory came in at $1.0 million for Q3 2023 at Perspective Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.6 million in Q3 2022 to a low of $501000.0 in Q3 2019.
  • Average Inventory over 5 years is $921842.1, with a median of $980000.0 recorded in 2021.
  • Year-over-year, Inventory surged 65.37% in 2021 and sank 34.77% in 2023.
  • Over 5 years, Inventory stood at $545000.0 in 2019, then climbed by 22.02% to $665000.0 in 2020, then surged by 60.6% to $1.1 million in 2021, then jumped by 31.93% to $1.4 million in 2022, then declined by 28.11% to $1.0 million in 2023.
  • Per Business Quant data, the three most recent Inventory figures were $1.0 million in Q3 2023, $1.1 million in Q2 2023, and $1.4 million in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 6.22 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.95 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.77 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 3.08 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 371.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 280.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 97.11 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.38 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Perspective Therapeutics 361.95 Mn 361.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.09 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.41 Mn
Sep 30, 2022 1.55 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 1.16 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 1.06 Mn
Jun 30, 2021 980,000.00
Mar 31, 2021 731,000.00
Dec 31, 2020 665,000.00
Sep 30, 2020 641,000.00
Jun 30, 2020 645,000.00
Mar 31, 2020 580,000.00
Dec 31, 2019 545,000.00
Sep 30, 2019 501,000.00
Jun 30, 2019 530,000.00
Mar 31, 2019 533,000.00
Dec 31, 2018 494,000.00